Skip to main content

TriPath Shareholders OK BD's $350M Acquisition Bid

NEW YORK (GenomeWeb News) — TriPath Imaging today said that its shareholders have approved Becton Dickinson’s $350-million bid to acquire the company.
 
The company said it expects the deal to close by tomorrow.
 
In September, BD said it would acquire 93.5 percent of TriPath’s shares for $350 million. TriPath said today that BD has agreed to pay $9.25 a share for the firm’s common stock, which is where the stock was trading this afternoon.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.